Energy expenditure and physical activity in clozapine use: implications for weight management

References

• Allison D B, Mentore J L, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 1999; 156: 1686–1696
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity – the evidence report. Obesity Research 1998; 6: 51S–209S
   Google Scholar
• Weiden P J, Mackell J A, McDonnell D D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 2003; 18: 1–7
   Google Scholar
• Allison D B, Mackell J A, McDonnell D D. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatric Services 2003; 54: 565–567
   PubMed Web of Science ®Google Scholar
• Baptista T, Zarate J, Joober R, et al. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. Current Drug Targets 2004; 5: 279–299
   PubMed Web of Science ®Google Scholar
• Gothelf D, Falk B, Singer P, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. American Journal of Psychiatry 2002; 159: 1055–1057
   PubMed Web of Science ®Google Scholar
• Graham K A, Perkins D O, Edwards L J, Barrier R C, Jr, Lieberman J A, Harp J B. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. American Journal of Psychiatry 2005; 162: 118–123
   PubMed Web of Science ®Google Scholar
• Schoeller D A. Recent advances from application of doubly labelled water to measurement of human energy expenditure. Journal of Nutrition 1999; 129: 1765–1768
   PubMed Web of Science ®Google Scholar
• Coward W A. The doubly-labelled water (2H218O) method: principles and practice. Proceedings of the Nutrition Society. 1988; 47: 209–218
   Google Scholar
• FAO/WHO/UNU. Energy and Protein Requirements. Technical Report Series No 724, Geneva 1985, Report of a joint FAO/WHO Ad Hoc Expert Committee
   Google Scholar
• Westerterp K R, Meijer E P. Physical activity and parameters of aging: a physiological perspective. Journal of Geronotology Association Series A Biological Sciences and Medical Sciences 2001; 56(Spec No 2)7–12
   PubMed Web of Science ®Google Scholar
• Black A E, Coward W A, Cole T J, Prentice A M. Human energy expenditure in affluent societies: an analysis of 574 doublylabelled water measurements. European Journal of Clinical Nutrition 1996; 50: 72–92
   PubMed Web of Science ®Google Scholar
• Institute of Medicine of the National Academies. Doubly labeled water data set, [Cited 30 June 2005.] Available from URL: http://www.iom.edu/Object.File/Master/7/302/DGW%20
   Google Scholar
• Byrne N M, Hills A P. Relationships between HR and VO2 in the obese. Medicine and Science in Sports and Exercise 2002; 34: 1419–1427
   PubMed Web of Science ®Google Scholar
• Weir J B. New methods for calculating metabolic rate with special reference to protein metabolism. Journal of Physiology 1949; 109: 1–9
   PubMed Web of Science ®Google Scholar
• Schoeller D A, Jefford G. Determinants of the energy costs of light activities: interpreting doubly labelled water. International Journal of Obesity 2002; 26: 94–101
   Web of Science ®Google Scholar
• World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894, Geneva 2000, Report of a WHO consultation
   Google Scholar
• Wing J, Beevor A S, Curtis R H, Park S B.G, Hadden S, Burns A. Health of the Nation Outcomes Scales: research and development. British Journal of Psychiatry 1998; 172: 11–18
   PubMed Web of Science ®Google Scholar
• Sharpe J K, Byrne N M, Stedman T J, Hills A P. Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication. Journal of the American Dietetic Association 2005; 105: 612–615
   PubMedGoogle Scholar
• Weinsier R L, Hunter G R, Desmond R A, Byrne N M, Zuckerman P A, Darnell B E. Free-living activity energy expenditure in women successful and unsuccessful at maintaining a normal body weight. American Journal of Clinical Nutrition 2002; 75: 499–504
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Knowler W C. Reduced rate of energy expenditure as a risk factor for body-weight gain. New England Journal of Medicine 1988; 318: 467–472
   PubMed Web of Science ®Google Scholar
• Brar J S, Ganguli R, Padina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 2005; 66: 205–212
   PubMed Web of Science ®Google Scholar
• Littrell K H, Hilligoss N M, Kirshner C D, Petty R G, Johnson C G. The effects of an educational intervention on antipsychoticinduced weight gain. Journal of Nursing Scholarship 2003; 35: 237–241
   PubMed Web of Science ®Google Scholar
• Gough S, Peveler R. Diabetes and its prevention: pragmatic solutions for people with schizophrenia. British Journal of Psychiatry 2004; 184: S112–S14
   Web of Science ®Google Scholar
• Ball M P, Coons V B, Buchanan R W. A program for treating olanzapine-related weight gain. Psychiatric Services 2001; 52: 967–969
   PubMed Web of Science ®Google Scholar
• Epstein L H, Valoski A M, Varn L S. Effects of decreasing sedentary behavior and increasing activity on weight change in obese children. Health Psychology 1995; 14: 109–115
   PubMed Web of Science ®Google Scholar